Optimal dose of tirzepatide for type 2 diabetes mellitus: a meta-analysis and trial sequential analysis

HIGHLIGHTS

• who: Weixiong Jian from the Temple University, United States have published the research work: Optimal dose of tirzepatide for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis, in the Journal: (JOURNAL)
• what: The authors used three mainstream doses of TZP 5 mg, 10 mg and 15 mg to evaluate the relative efficacy and safety of different doses of TZP for the treatment of T2DM by using meta-analysis and trial sequential analysis (TSA), to provide an evidentiary basis for the selection of clinical doses. There are some differences in the study compared . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.